Univest
Univest
  • Markets

  • 3 Finished Dosage Generics, Anti-Retroviral and Active Ingredient Leader and Complex Oncology Generics Stocks With a Strong Future Roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma

    • October 23, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Finished Dosage Generics, Anti-Retroviral and Active Ingredient Leader and Complex Oncology Generics Stocks With a Strong Future Roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma

    US Generics and Complex Oncology Drug Stocks with a strong future roadmap: Strides Pharma Science, Laurus Labs and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.

    read more